Previous close | 0.0040 |
Open | 0.0050 |
Bid | 0.0040 x 0 |
Ask | 0.0050 x 0 |
Day's range | 0.0040 - 0.0050 |
52-week range | 0.0040 - 0.0200 |
Volume | |
Avg. volume | 3,041,818 |
Market cap | 5.204M |
Beta (5Y monthly) | 2.07 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0100 |
Earnings date | 28 Feb 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 0.03 |
Elixinol Wellness Limited (ASX: EXL) continues to be a pioneer in the global hemp industry, with the release of a new paper into the safety of Elixinol Hemp Extract in leading scientific publication, Journal of Toxicology.
Elixinol Wellness ( ASX:EXL ) First Half 2023 Results Key Financial Results Revenue: AU$3.46m (up 7.4% from 1H 2022...